Stay updated on Nivolumab in Hodgkin's Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Hodgkin's Lymphoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to include the latest version of the publication regarding Nivolumab for relapsed/refractory classic Hodgkin lymphoma, reflecting a revision from v2.15.0 to v2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T06:16:28.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding Nivolumab's efficacy and safety in treating classical Hodgkin Lymphoma, while a new version number has been added.
    Difference
    4%
    Check dated 2025-04-16T20:28:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T13:58:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-02T00:13:57.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-24T22:58:33.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T16:07:39.000Z thumbnail image

Stay in the know with updates to Nivolumab in Hodgkin's Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.